CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-16 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,799 | $67.53 | $121K | 84,797 |
| 2025-05-15 | Bonstein Sara Chief Financial Officer | Grant or award | +6,508 | 114,867 | ||
| 2025-05-15 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +31,610 | 31,610 | ||
| 2025-05-15 | Adsett Roger Chief Operating Officer | Grant or award | +6,508 | 143,183 | ||
| 2025-05-15 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) | +31,610 | 31,610 | ||
| 2025-05-15 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award | +5,578 | 120,221 | ||
| 2025-05-15 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award · Stock Option (right to buy) | +27,100 | 27,100 | ||
| 2025-05-15 | Lewis William Chair and CEO | Grant or award | +22,314 | 335,287 | ||
| 2025-05-15 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +108,380 | 108,380 | ||
| 2025-05-15 | Flammer Martina M.D. Chief Medical Officer | Grant or award 10b5-1 | +6,508 | 96,521 | ||
| 2025-05-15 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −9,925 | $65.47 | $650K | 86,596 |
| 2025-05-15 | Flammer Martina M.D. Chief Medical Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +31,610 | 31,610 | ||
| 2025-05-15 | Smith Michael Alexander Chief Legal Officer | Grant or award | +5,578 | 97,372 | ||
| 2025-05-15 | Smith Michael Alexander Chief Legal Officer | Grant or award · Stock Option (right to buy) | +27,100 | 27,100 | ||
| 2025-05-15 | Brennan David R Director | Grant or award | +5,058 | 126,933 | ||
| 2025-05-15 | SCHAFER CAROL Director | Grant or award | +5,058 | 63,317 | ||
| 2025-05-15 | Desjardins Clarissa Director | Grant or award | +5,058 | 67,007 | ||
| 2025-05-15 | SHAROKY MELVIN MD Director | Grant or award | +5,058 | 301,216 | ||
| 2025-05-15 | ANDERSON ELIZABETH M Director | Grant or award | +5,058 | 73,729 | ||
| 2025-05-15 | MCGIRR DAVID W J Director | Grant or award | +5,058 | 103,973 |
Page 25 of 42 · 826 trades